Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00144911
Status:
COMPLETED
Last Update Posted:
2016-10-28
First Post:
2005-09-01
Brief Title:
ADVAIR DISKUS Inhaler Fluticasone PropionateSalmeterol Versus SEREVENT DISKUS Inhaler Salmeterol For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations ADVAIR DISKUS Inhaler and SEREVENT DISKUS Inhaler Are Trademarks of the GSK Group of Companies
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline